• 1
    K Kasagi. [Epidemiology of thyroid tumors: effect of environmental iodine intake]. Nippon Rinsho. 2007; 65: 1953-1958.
  • 2
    Kent WD, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ. 2007; 177: 1357-1361.
  • 3
    Colonna M, Guizard AV, Schvartz C, et al. A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from 6 cancer registries in France. 1983-2000. Eur J Cancer. 2007; 43: 891-900.
  • 4
    Burgess JR, Tucker P. Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid. 2006; 16: 47-53.
  • 5
    Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006; 295: 2164-2167.
  • 6
    How J, Tabah R. Explaining the increasing incidence of differentiated thyroid cancer. CMAJ. 2007; 177: 1383-1384.
  • 7
    Hedinger, C, Williams ED, Sobin LH. Histological Typing of Thyroid Tumours (WHO. World Health Organization. International Histological Classification of Tumours). New York: Springer; 1993.
  • 8
    Roti E, Rossi R, Trasforini G, et al. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab. 2006; 91: 2171-2178.
  • 9
    Baloch ZW, LiVolsi VA. Microcarcinoma of the thyroid. Adv Anat Pathol. 2006; 13: 69-75.
  • 10
    Nasir A, Chaudhry AZ, Gillespie J, Kaiser HE, Papillary microcarcinoma of the thyroid: a clinico-pathologic and prognostic review. In Vivo. 2000; 14: 367-376.
  • 11
    Piersanti M, Ezzat S, Asa SL. Controversies in papillary microcarcinoma of the thyroid. Endocr Pathol. 2003; 14: 183-191.
  • 12
    Ron E, Schneider AB. Thyroid Cancer. In: SchottenfeldD, FraumeniJFJr, eds. Cancer Epidemiology and Prevention. New York: Oxford University Press; 2006: 975-994.
  • 13
    United Nations Scientific Committee on the Effects of Atomic Radiation, Sources and effects of ionizing radiation: United Nations Scientific Committee on the Effects of Atomic Radiation UNSCEAR 2000 Report to the General Assembly, with scientific annexes, Vol 2: Effects. United Nations, New York, 2000.
  • 14
    Young RW, Kerr GD, eds. Reassessment of the Atomic-Bomb Radiation Dosimetry for Hiroshima and Nagasaki: Dosimetry System 2002 Radiation Effects Research Foundation, Hiroshima, Japan, 2005.
  • 15
    Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res. 2003; 160: 381-407.
  • 16
    Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 2007; 168: 1-64.
  • 17
    Mabuchi K, Soda M, Ron E, et al. Cancer incidence in atomic bomb survivors. Part I: use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat Res. 1994; 137( suppl 2): S1-S16.
  • 18
    Angevine DM, Jablon S, Matsumoto YS. JNIH-ABCC pathology studies, Hiroshima-Nagasaki report 1, October 1950-September 1960. Natl Cancer Inst Monogr. 1963; 19: 445-465.
  • 19
    Beebe GW, Yamamoto T, Matsumoto YS, Gould SE. ABCC-JNIH pathology studies, Hiroshima-Nagasaki report 2, October 1950-December 1965, Hiroshima Igaki. 1968; 21: 729-735.
  • 20
    ABCC-JNIH pathology studies research plan. Radiation Effects Research Foundation, Hiroshima, 1962.
  • 21
    Pierce DA, Stram DO, Vaeth M. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res. 1990; 123: 275-284.
  • 22
    Preston DL, Lubin JH, Pierce DA, McConney ME. Epicure users guide. Hirosoft International Corporation, Seattle, Washington, 1993.
  • 23
    Yamamoto Y, Maeda T, Izumi K, Otsuka H. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer. 1990; 65: 1173-1179.
  • 24
    de Matos PS, Ferreira AP, Ward LS. Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series. Endocr Pathol. 2006; 17: 165-173.
  • 25
    Kaneko N, Numata J. An autopsy case of atomic radiation-induced leukmia complicated with thyroid gland tumor [in Japanese]. J Pediatr Pract. 1957; 20: 478.
  • 26
    Fujimoto Y, Yamamoto T, Numata J, Mori K. Two autopsy cases of thyroid cancer in young atomic bomb survivors [in Japanese]. J Hiroshima Med Assoc. 1959; 12: 519-524.
  • 27
    Hollingsworth DR. Radiation and carcinoma of the thyroid. Conn Med. 1963; 27: 762-765.
  • 28
    Socolow EL, Hashizume A, Neriishi S, Niitani R. Thyroid carcinoma in man after exposure to ionizing radiation. A summary of the findings in Hiroshima and Nagasaki. N Engl J Med. 1963; 268: 406-410.
  • 29
    Wood JW, Tamagaki H, Neriishi S, et al. Thyroid carcinoma in atomic bomb survivors Hiroshima and Nagasaki. Am J Epidemiol. 1969; 89: 4-14.
  • 30
    Parker LN, Belsky JL, Yamamoto T, Kawamoto S, Keehn RJ. Thyroid carcinoma after exposure to atomic radiation. A continuing survey of a fixed population, Hiroshima and Nagasaki, 1958-1971. Ann Intern Med. 1974; 80: 600-604.
  • 31
    Sampson RJ, Key CR, Buncher CR, Iijima S. Thyroid carcinoma in Hiroshima and Nagasaki. I. Prevalence of thyroid carcinoma at autopsy. JAMA. 1969; 209: 65-70.
  • 32
    Sampson RJ, Key CR, Buncher CR, Iijima S. The smallest forms of papillary carcinoma of the thyroid. A study of 141 microcarcinomas less than 0.1 cm in greatest dimension. Arch Pathol. 1971; 91: 334-339.
  • 33
    Yoshimoto Y, Ezaki H, Etoh R, Hiraoka T, Akiba S. Prevalence rate of thyroid diseases among autopsy cases of the atomic bomb survivors in Hiroshima, 1951-1985. Radiat Res. 1995; 141: 278-286.
  • 34
    Richardson DB. Exposure to ionizing radiation in adulthood and thyroid cancer incidence. Epidemiology. 2009; 20: 181-187.
  • 35
    Damber L, Larsson LG, Johansson L, Norin T. A cohort study with regard to the risk of haematological malignancies in patients treated with x-rays for benign lesions in the locomotor system. I. Epidemiological analyses. Acta Oncol. 1995; 34: 713-719.
  • 36
    Huang J, Walker R, Groome PG, Shelley W, Mackillop WJ. Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma. Cancer. 2001; 92: 1411-1418.
  • 37
    Ronckers CM, Erdmann CA, Land CE. Radiation and breast cancer: a review of current evidence. Breast Cancer Res. 2005; 7: 21-32.
  • 38
    Roychoudhuri R, Evans H, Robinson D, Moller H. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer. 2004; 91: 868-872.
  • 39
    Adjadj E, Rubino C, Shamsaldim A, Le MG, Schlumberger M, de Vathaire F. The risk of multiple primary breast and thyroid carcinomas. Cancer. 2003; 98: 1309-1317.